Key points from article :
A new vaccine for early bowel cancer is set to undergo trials in England and Australia.
The vaccine will be administered to patients prior to surgery in hopes of stimulating the body's immune response against the cancer.
The trial will enroll 44 patients over 18 months across 10 sites, four in the UK and six in Australia, conducted by Cancer Research UK Southampton Clinical Trials Unit.
Patients will receive three doses of the vaccine before undergoing surgery to remove the cancer.
The vaccine, designed by Imugene Ltd, aims to potentially eliminate the need for surgery and marks a significant advancement in bowel cancer treatment.
